Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > Stunning timing... Epic!
View:
Post by prophetoffactz on Dec 22, 2023 12:45pm

Stunning timing... Epic!

The S&P Biotech ETF is now up 37% in less than 2 months and about 5% from its high for the year. It is on fire. Stunning timing. Gilles has potentially picked off the AEZS assets right at the bottom of the market in a legendary manner. AEZS has been ~100% higher in the last year compared to where it is trading right now.

C$50 million cash, C$113 million in tax loss carryforwards, a diagnostic cashcow about to be partnered with its most important market potentially approved in 2024, a pipeline of other assets(eg. AIM Biologicals).

Stunning timiing...

He called it:

"The combination is attractive for shareholders of both companies, as it is expected to create a long-term sustainable business, which is optimally positioned to deliver value as the biopharma sector recovers from its current levels." news release
Comment by boazklinghorn on Dec 22, 2023 1:00pm
LOL its like whack-a-mole with the Proph you can rhetorically pummel him all day long but he always pops back up. 
Comment by boazklinghorn on Dec 22, 2023 1:01pm
FYI new low today. Market loves this deal. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities